BioCryst Pharma (BCRX) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts BCRX Hot Sheet
Price: $9.84 +1.97%
Revenue Growth %: +13.7%
Financial Fact:
Total expenses: 17M
Today's EPS Names:
CRMT, More
Revenue Growth %: +13.7%
Financial Fact:
Total expenses: 17M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
BioCryst Pharma (NASDAQ: BCRX) reported Q4 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $4.6 million versus the consensus estimate of $6.34 million.
For earnings history and earnings-related data on BioCryst Pharma (BCRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
- Isabella Bank added to Russell 2000 index after Nasdaq listing
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
